BRIEF-Alcobra establishes special committee to explore, evaluate strategic alternatives

June 23 (Reuters) - Alcobra Ltd (ADHD.O) :

* Alcobra updates on its review of strategic alternatives

* Says company also intends to streamline its operations in order to preserve its capital and cash resources

* Says board has established a special committee to explore and evaluate strategic alternatives

* Alcobra - is continuing to assess best path forward for its abuse-deterrent amphetamine immediate-release (Adair), metadoxine extended release (MDX) clinical programs

* Alcobra Ltd says potential strategic alternatives that may be explored include potential for an acquisition, merger, business combination

* Alcobra Ltd says potential strategic alternatives that may be explored also include other strategic transaction involving company

* Says engaged Ladenburg Thalmann & Co Inc to act as its strategic financial advisor for strategic alternatives process

Source text for Eikon: Further company coverage: (ADHD.O)